Vertex Falls After FDA Halts Diabetes Study in Surprise Move (1) - Bloomberg Law
Vertex Pharmaceuticals Inc. tumbled after U.S. regulators placed its study of a key new treatment for type 1 diabetes on clinical hold. The Food and Drug Administration paused the early-stage stu...
Read more